Terumo Corp
TSE:4543

Watchlist Manager
Terumo Corp Logo
Terumo Corp
TSE:4543
Watchlist
Price: 3 073 JPY 1.15% Market Closed
Market Cap: 4.6T JPY
Have any thoughts about
Terumo Corp?
Write Note

Intrinsic Value

The intrinsic value of one Terumo Corp stock under the Base Case scenario is 2 428.38 JPY. Compared to the current market price of 3 073 JPY, Terumo Corp is Overvalued by 21%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
2 428.38 JPY
Overvaluation 21%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Terumo Corp

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Terumo Corp cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Terumo Corp?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Terumo Corp

Provide an overview of the primary business activities
of Terumo Corp.

What unique competitive advantages
does Terumo Corp hold over its rivals?

What risks and challenges
does Terumo Corp face in the near future?

Summarize the latest earnings call
of Terumo Corp.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Terumo Corp.

Provide P/S
for Terumo Corp.

Provide P/E
for Terumo Corp.

Provide P/OCF
for Terumo Corp.

Provide P/FCFE
for Terumo Corp.

Provide P/B
for Terumo Corp.

Provide EV/S
for Terumo Corp.

Provide EV/GP
for Terumo Corp.

Provide EV/EBITDA
for Terumo Corp.

Provide EV/EBIT
for Terumo Corp.

Provide EV/OCF
for Terumo Corp.

Provide EV/FCFF
for Terumo Corp.

Provide EV/IC
for Terumo Corp.

Show me price targets
for Terumo Corp made by professional analysts.

What are the Revenue projections
for Terumo Corp?

How accurate were the past Revenue estimates
for Terumo Corp?

What are the Net Income projections
for Terumo Corp?

How accurate were the past Net Income estimates
for Terumo Corp?

What are the EPS projections
for Terumo Corp?

How accurate were the past EPS estimates
for Terumo Corp?

What are the EBIT projections
for Terumo Corp?

How accurate were the past EBIT estimates
for Terumo Corp?

Compare the revenue forecasts
for Terumo Corp with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Terumo Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Terumo Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Terumo Corp compared to its peers.

Compare the P/E ratios
of Terumo Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Terumo Corp with its peers.

Analyze the financial leverage
of Terumo Corp compared to its main competitors.

Show all profitability ratios
for Terumo Corp.

Provide ROE
for Terumo Corp.

Provide ROA
for Terumo Corp.

Provide ROIC
for Terumo Corp.

Provide ROCE
for Terumo Corp.

Provide Gross Margin
for Terumo Corp.

Provide Operating Margin
for Terumo Corp.

Provide Net Margin
for Terumo Corp.

Provide FCF Margin
for Terumo Corp.

Show all solvency ratios
for Terumo Corp.

Provide D/E Ratio
for Terumo Corp.

Provide D/A Ratio
for Terumo Corp.

Provide Interest Coverage Ratio
for Terumo Corp.

Provide Altman Z-Score Ratio
for Terumo Corp.

Provide Quick Ratio
for Terumo Corp.

Provide Current Ratio
for Terumo Corp.

Provide Cash Ratio
for Terumo Corp.

What is the historical Revenue growth
over the last 5 years for Terumo Corp?

What is the historical Net Income growth
over the last 5 years for Terumo Corp?

What is the current Free Cash Flow
of Terumo Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Terumo Corp.

Business Breakdown

Terumo Corporation, founded in 1921 and headquartered in Tokyo, Japan, has carved a significant niche in the global healthcare landscape as a leader in medical technology. With a steadfast commitment to enhancing the quality of life, Terumo focuses on innovative solutions in areas such as blood management, cardiovascular interventions, and surgical devices. Through a history of groundbreaking research and development, Terumo has established a robust portfolio of products that not only meet immediate clinical needs but also pave the way for advancements in patient care. The company’s dedication to sustainability and social responsibility further solidifies its reputation as a trustworthy and...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Terumo Corp

Current Assets 679.2B
Cash & Short-Term Investments 195.3B
Receivables 165.7B
Other Current Assets 318.2B
Non-Current Assets 1.1T
Long-Term Investments 41.5B
PP&E 412.2B
Intangibles 546.6B
Other Non-Current Assets 72.8B
Current Liabilities 231B
Accounts Payable 94B
Accrued Liabilities 27.8B
Other Current Liabilities 109.3B
Non-Current Liabilities 207.7B
Long-Term Debt 159.8B
Other Non-Current Liabilities 47.9B
Efficiency

Earnings Waterfall
Terumo Corp

Revenue
986.7B JPY
Cost of Revenue
-456.9B JPY
Gross Profit
529.8B JPY
Operating Expenses
-368.5B JPY
Operating Income
161.3B JPY
Other Expenses
-41.8B JPY
Net Income
119.5B JPY

Free Cash Flow Analysis
Terumo Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In the first half of FY 2025, Terumo reported a remarkable 15% revenue growth, reaching JPY 508.7 billion, driven by high demand and effective pricing measures. Operating income rose to JPY 87.7 billion, with a forecasted adjusted operating income increase from JPY 185 billion to JPY 200 billion for the full year. Free cash flow also reached a record, bolstering financial stability. The company is innovating in the vascular field, specifically in venous interventions, fueled by a growing market and strategic expansions. Despite potential risks from macroeconomic factors, management remains optimistic about sustaining this growth trajectory.

What is Earnings Call?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Terumo Corp's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Operating Income
56/100
Profitability
Score

Terumo Corp's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Terumo Corp's solvency score is 91/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Low D/E
91/100
Solvency
Score

Terumo Corp's solvency score is 91/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Terumo Corp

Wall Street analysts forecast Terumo Corp stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Terumo Corp is 3 456.23 JPY with a low forecast of 3 030 JPY and a high forecast of 4 000.5 JPY.

Lowest
Price Target
3 030 JPY
1% Downside
Average
Price Target
3 456.23 JPY
12% Upside
Highest
Price Target
4 000.5 JPY
30% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Terumo Corp?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Terumo Corp is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Terumo Corp Logo
Terumo Corp

Country

Japan

Industry

Health Care

Market Cap

4.6T JPY

Dividend Yield

0.78%

Description

Terumo Corp. engages in the manufacturing and sale of medical products and equipment. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 26,482 full-time employees. The firm operates in three segments. The Cardiac and Vascular Company segment is engaged in the manufacture of catheter system and cardiopulmonary system products, the import of the cardiopulmonary systems and artificial blood vessels, as well as the sale of products mainly to hospitals and clinics nationwide through agents. The Hospital Company segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The segment is also engaged in the manufacture and sale of healthcare related products. The Blood System Company segment is engaged in the manufacture and sale of blood transfusion-related products.

Contact

TOKYO-TO
Shibuya-Ku
2-44-1, Hatagaya
+81333748111.0
www.terumo.co.jp

IPO

1982-06-21

Employees

26 482

Officers

Chairman of the Board & Group Managing Executive Officer
Mr. Toshiaki Takagi
Representative Director, President & CEO
Mr. Hikaru Samejima
CFO, CIO, GM of CFO Office, Controller & Treasury Tax Dept., J-SOX Office, IT Planning Dept. & GBS
Jin Hagimoto
CTO, GM of DX Promotion Dept. R&D Division and Executive Officer
Shinji Omori
Executive Officer, Chief Legal Officer and GM of CLO Office, Legal & Compliance Department
Ms. Miho Mizuguchi
Chief Human Resources Officer & Group Executive Officer
Tomoko Adachi
Show More
Director & Group Managing Executive Officer
Mr. Kazunori Hirose
Group Senior Managing Executive Officer & Director
Toshihiko Osada
Group Managing Executive Officer
Fumihisa Hirose
Show Less

See Also

Discover More
What is the Intrinsic Value of one Terumo Corp stock?

The intrinsic value of one Terumo Corp stock under the Base Case scenario is 2 428.38 JPY.

Is Terumo Corp stock undervalued or overvalued?

Compared to the current market price of 3 073 JPY, Terumo Corp is Overvalued by 21%.

Back to Top